Transcription of ICH HARMONISED TRIPARTITE GUIDELINE
{{id}} {{{paragraph}}}
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL. REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH HARMONISED TRIPARTITE GUIDELINE . good manufacturing PRACTICE GUIDE FOR. ACTIVE PHARMACEUTICAL INGREDIENTS. Q7. Current Step 4 version dated 10 November 2000. This GUIDELINE has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA. Q7. Document History New First Codification History Date Codification November 2005. Q7A Approval by the Steering Committee under Step 2 and 19 Q7. release for public consultation. July 2000. Current Step 4 version Q7A Approval by the Steering Committee under Step 4 and 10 Q7. recommendation for adoption to the three ICH regulatory November bodies.
GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 10 November 2000, this guideline is recommended for adoption to the three regulatory parties to ICH
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
WHO guidelines on, WHO guidelines on good manufacturing practices, SUPPLEMENTARY GUIDELINES ON GOOD, Guidelines, GOOD MANUFACTURING PRACTICES, Guidelines for Developing and ESTRs, Guidelines for Developing Good Manufacturing Practices, Certified Pharmaceutical Good Manufacturing Practices, Good Agricultural Practices, Good Agricultural and Manufacturing (Handling) Safety, Practices, PrimusGFS Audit GMP (Module 2) Guidelines